6533b838fe1ef96bd12a3d20
RESEARCH PRODUCT
GLP-1 receptor agonists, carotid atherosclerosis and retinopathy
Manfredi RizzoFrancesco PaceNicola MontanoNikolaos PapanasDragana Nikolicsubject
PharmacologyCarotid atherosclerosismedicine.medical_specialtybusiness.industryglucagon-like peptide 1 receptor agonistscarotid atherosclerosis030209 endocrinology & metabolismGeneral Medicine030204 cardiovascular system & hematologyCardiovascular riskmedicine.disease03 medical and health sciences0302 clinical medicinePremature atherosclerosisDiabetes mellitusInternal medicineretinopathymedicineCardiologyPharmacology (medical)businessGlucagon-like peptide 1 receptorRetinopathydescription
It is known that diabetes is associated with the development of premature atherosclerosis and microvascular complications and consequently increased cardiovascular (CV) morbidity and mortality. In ...
year | journal | country | edition | language |
---|---|---|---|---|
2017-06-15 | Expert Opinion on Pharmacotherapy |